Arkolith/Insider Trading/ZBIO/Form 4

Lu Hongbo

DirectorZenas BioPharma, Inc. (ZBIO) · full profile →Form 4 · filed Oct 9, 2025
Net Buying
Open-Market Buys
$6.0M
Open-Market Sells
$0
Net Open-Market Flow
$6.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2025Buy(P)263K$19.00$5.0M322K
Sep 13, 2024Buy(P)59K$17.00$1000K59K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-25-006031) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML